<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC141761_doc-5-1-42-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasTextChunk>	<http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC141761_doc-5-1-42-2-28552-28556> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC141761_doc-5-1-42-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasTextChunk>	<http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC141761_doc-5-1-42-2-28631-28635> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC141761_doc-5-1-42-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://salt.semanticauthoring.org/ontologies/sdo#Sentence> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC141761_doc-5-1-42-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasText>	"V anal\u00FDze podskupin zalo\u017Een\u00E9 na pohlav\u00ED (81% mu\u017E\u016F a 19% \u017Een) bylo mo\u017Eno sledovat prosp\u011B\u0161n\u00FD \u00FA\u010Dinek z pou\u017Eit\u00ED atorvastatinu u mu\u017E\u016F, ale nemohl b\u00FDt stanoven u \u017Een pravd\u011Bpodobn\u011B v d\u016Fsledku mal\u00E9ho po\u010Dtu p\u0159\u00EDhod v \u017Eensk\u00E9 podskupin\u011B."@cs .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC141761_doc-5-1-42-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasStartPointer>	"28507"^^<http://www.w3.org/2001/XMLSchema#long> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC141761_doc-5-1-42-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasEndPointer>	"28732"^^<http://www.w3.org/2001/XMLSchema#long> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC141761_doc-5-1-42-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasOrderNumber>	"2"^^<http://www.w3.org/2001/XMLSchema#int> .